XML 36 R29.htm IDEA: XBRL DOCUMENT v3.24.3

Stockholders' Deficit (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Number of Common Stock Reserved for Future Issuance

As of September 30, 2024 and December 31, 2023, the Company had reserved common stock for future issuance as follows:

		September 30,				December 31,
		2024				2023
Conversion of Series Seed redeemable convertible preferred stock			1,218,208				1,218,208
Conversion of Series A redeemable convertible preferred stock			3,026,755				3,026,755
Conversion of Series B redeemable convertible preferred stock			4,648,714				4,648,714
Conversion of Series C redeemable convertible preferred stock			8,923,966				8,923,966
Conversion of Series B warrants			45,726				45,726
Conversion of Series C-1 warrants			56,573				15,228
Outstanding options under the 2014 Plan			4,120,841				4,746,527
Outstanding options under the 2024 EIP			1,556,057				—
Outstanding RSUs under the 2024 EIP			19,843				—
Options reserved for future issuance under the 2014 Plan			—				409,017
Options reserved for future issuance under the 2024 EIP			136,429				—
Total			23,753,112				23,034,141

Schedule Of Activity Under The Plans

Activity under the plans is as follows:

										Weighted average				Aggregate
		Number of				Weighted average				remaining contractual				intrinsic value
		options				exercise price				life (years)				(thousands)
Balance at December 31, 2023			4,746,527			$	4.04				8.17				13,383
Options granted			1,713,753				11.68
Options exercised			(348,943	)			2.69
Options forfeited			(434,439	)			5.12
Balance at September 30, 2024			5,676,898				6.35				7.91				59,386
Shares outstanding, vested, and expected to vest at September 30, 2024			5,676,898				6.35				7.91				59,386
Shares exercisable at September 30, 2024			2,555,661			$	3.76				6.75				33,358

Schedule of Assumptions Used for Estimate of Fair Value of Options

The fair value of employee stock options granted was estimated using the following weighted-average assumptions:

		Three months ended September 30,										Nine months ended September 30,
		2024					2023					2024					2023
Expected term (in years)			5.5					5.1					5.4					5.0
Expected volatility			63.4		%			74.5		%			68.3		%			75.6		%
Risk-free interest rate			3.8		%			4.5		%			4.1		%			4.1		%
Dividend yield		—					—					—					—

Schedule Of Total Stock Based Compensation Expense

The Company’s total stock-based compensation expense was as follows (in thousands):

		Three months ended September 30,										Nine months ended September 30,
		2024					2023					2024					2023
Sales and marketing		$	395				$	158				$	837				$	495
General and administrative			792					351					1,894					1,103
Research and development			189					128					478					335
Total stock-based compensation expense		$	1,376				$	637				$	3,209				$	1,933

X

- Definition

Schedule of common stock reserved for future issuance.

+ References

No definition available.

+ Details

Name:	cbll_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix:	cbll_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration